Equity securities

Global Pharma, Biotech and Diagnostics Agreements 2014-2020: Company A-Z, Headline Value, Stage of Development at Signing, Therapeutic Area, Technology Type

Retrieved on: 
Tuesday, October 20, 2020
Intellectual property law, Patent law, Expense, Royalty payment, Corporate finance, Finance, Money, Equity securities, Economy, Royalty fund

The Global Asset Purchase Deals in Pharma, Biotech and Diagnostics 2014-2020 report provides a detailed understanding and analysis of how and why companies enter business, product, technology and royalty assets.

Key Points: 
  • The Global Asset Purchase Deals in Pharma, Biotech and Diagnostics 2014-2020 report provides a detailed understanding and analysis of how and why companies enter business, product, technology and royalty assets.
  • The report provides a detailed understanding and analysis of how and why companies enter business, product, technology and royalty assets.
  • The focus of the report is on partnerships for business, product, technology and royalty assets where partners have entered an agreement to dispose of or acquire said assets.
  • Insight into the terms included in a asset purchase agreement, together with real world clause examples
    Available deals are listed by:

SWEF: Transaction in Own Shares

Retrieved on: 
Tuesday, October 20, 2020
Stock market, Equity securities, Share, Corporations, Corporate finance, Economy, Corporate law, Transparency Directive

Following the purchase of these shares, the Company will have 413,219,398 shares in issue.

Key Points: 
  • Following the purchase of these shares, the Company will have 413,219,398 shares in issue.
  • The Company holds 1,822,000 shares in treasury.
  • Therefore, the total number of voting rights in the Company is 411,397,398, which may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

Atlas Technical Consultants, Inc. Announces Commencement of Exchange Offer and Consent Solicitation Relating to Warrants

Retrieved on: 
Monday, October 19, 2020
Financial markets, Financial economics, Finance, Corporate finance, Initial public offering, Equity securities, Options, Stock market, Warrant, Prospectus, Security, Shelf registration

Pursuant to the Offer, the Company is offering up to an aggregate of 4,393,750 shares of its Class A common stock in exchange for the warrants.

Key Points: 
  • Pursuant to the Offer, the Company is offering up to an aggregate of 4,393,750 shares of its Class A common stock in exchange for the warrants.
  • As of October 19, 2020, holders of approximately 53.1% of the total warrants outstanding have agreed to consent to the Warrant Amendment in the Consent Solicitation.
  • The Company has engaged BofA Securities, Inc. as the Dealer Manager for the Offer and Consent Solicitation.
  • The Offer and Consent Solicitation are being made only through the Schedule TO and Prospectus/Offer to Exchange, and the complete terms and conditions of the Offer and Consent Solicitation are set forth in the Schedule TO and Prospectus/Offer to Exchange.

CONCHO ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of CXO and Encourages Investors to Contact the Firm

Retrieved on: 
Monday, October 19, 2020
Financial markets, Financial economics, Corporate finance, Stock market, Finance, Equity securities, Concha, Common stock, Security, ConocoPhillips, Stock, Conoco

On October 19, 2020, Concho announced that it had signed an agreement to be acquired by ConocoPhillips for approximately $9.7 billion.

Key Points: 
  • On October 19, 2020, Concho announced that it had signed an agreement to be acquired by ConocoPhillips for approximately $9.7 billion.
  • Pursuant to the merger agreement, Concho stockholders will receive 1.46 shares of ConocoPhillips common stock for each share of Concho common stock owned.
  • Bragar Eagel & Squire is concerned that Conchos board of directors oversaw an unfair process and ultimately agreed to an inadequate merger agreement.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

Globus Maritime Limited Announces Reverse Stock Split

Retrieved on: 
Monday, October 19, 2020
Financial markets, Stock market, Financial economics, Finance, Corporate finance, Equity securities, Reverse stock split, Stock split, Stock, Common stock, Preferred stock

GLYFADA, Greece, Oct. 19, 2020 (GLOBE NEWSWIRE) -- Globus Maritime Limited ("Globus" or the Company,") (NASDAQ: GLBS), a dry bulk shipping company, announced today that its Board of Directors (the Board) has determined to effect a 1-for-100 reverse stock split of the Companys common shares and Series B preferred shares.

Key Points: 
  • GLYFADA, Greece, Oct. 19, 2020 (GLOBE NEWSWIRE) -- Globus Maritime Limited ("Globus" or the Company,") (NASDAQ: GLBS), a dry bulk shipping company, announced today that its Board of Directors (the Board) has determined to effect a 1-for-100 reverse stock split of the Companys common shares and Series B preferred shares.
  • At the Companys annual general meeting of shareholders on September 24, 2020, the Companys shareholders approved the reverse stock split and granted the Board the authority to determine the exact reverse split ratio and proceed with the reverse stock split.
  • The new CUSIP number for the common stock following the reverse stock split is Y27265 126.
  • No fractional shares will be issued in connection with the reverse split of the issued and outstanding common stock.

SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of EIDX, ARA, MVC, and CGIX Mergers

Retrieved on: 
Monday, October 19, 2020
Stock market, Financial economics, Corporate finance, Finance, Money, Equity securities, Common stock, Shareholder, Stock

Under the terms of the agreement, Eidos shareholders will receive 1.85 shares of BridgeBio common stock or $73.26 in cash per share.

Key Points: 
  • Under the terms of the agreement, Eidos shareholders will receive 1.85 shares of BridgeBio common stock or $73.26 in cash per share.
  • Under the terms of the agreement American Renal Associates shareholders will receive $11.50 per share in cash.
  • Under the terms of the agreement, Cancer Genetics will issue a number of shares of Cancer Genetics common stock to StemoniX shareholders.
  • You may also contact Seth D. Rigrodsky or Gina M. Serra cost and obligation free at (888) 969-4242 or [email protected] .

American Express Declares Dividends on Series B and Series C Preferred Stock

Retrieved on: 
Monday, October 19, 2020
Banking, Professional services, Finance, Financial markets, Finance, Equity securities, Stock market, Corporate finance, Shareholders, Preferred stock, Dividends

American Express Company (NYSE: AXP) has declared the following dividends on the Companys Series B and C Preferred Shares:

Key Points: 
  • American Express Company (NYSE: AXP) has declared the following dividends on the Companys Series B and C Preferred Shares:
    A quarterly dividend on the Companys 5.200% Fixed Rate / Floating Rate Noncumulative Preferred Shares, Series B, of $9,373.33 per share (which is equivalent to $9.37333 per related Depositary Share).
  • The dividend is payable on November 16, 2020, to shareholders of record on November 1, 2020.
  • A quarterly dividend on the Companys 4.900% Fixed Rate / Floating Rate Noncumulative Preferred Shares, Series C, of $8,936.66 per share (which is equivalent to $8.93666 per related Depositary Share).
  • American Express is a globally integrated payments company, providing customers with access to products, insights and experiences that enrich lives and build business success.

Kearny Financial Corp. Announces Resumption of Its Current Stock Repurchase Plan and Approval of a New 5% Stock Repurchase Plan

Retrieved on: 
Monday, October 19, 2020
Financial markets, Stock market, Financial economics, Corporate finance, Finance, Equity securities, Share repurchase, Common stock, Repurchase agreement, Stock, Targeted repurchase, Buyback

The current stock repurchase plan was temporarily suspended on March 25, 2020 due to the risks and uncertainties associated with the COVID-19 pandemic.

Key Points: 
  • The current stock repurchase plan was temporarily suspended on March 25, 2020 due to the risks and uncertainties associated with the COVID-19 pandemic.
  • Upon completion of its current stock repurchase plan, the Board of Directors has approved a new stock repurchase plan to acquire up to 4,475,523 shares or 5% of the Companys outstanding common stock.
  • Craig L. Montanaro, President & CEO noted, Since our second-step conversion in May of 2015 our share repurchase program has returned in excess of $500 million of capital to our stockholders.
  • As demonstrated by this most recent authorization, we believe that share repurchases remain an excellent strategy to build long-term shareholder value.

Sports Venues of Florida, Inc. (OTC:BTHR) Announces Reduction in Authorized Common Stock By 6.56 Billion Shares Effective October 15, 2020 -- Existing Shareholders Not Affected by This Corporate Action

Retrieved on: 
Monday, October 19, 2020
Financial markets, Financial economics, Stock market, Finance, Corporate finance, Equity securities, Shareholders, Stock dilution, Stock, Corporate action, Common stock, Treasury stock

The Company did not reverse its issued and outstanding common stock so existing shareholders will not be affected by this corporate action.

Key Points: 
  • The Company did not reverse its issued and outstanding common stock so existing shareholders will not be affected by this corporate action.
  • Management has listened to comments from its shareholders and a common theme shared by many was that the Company had too many authorized shares.
  • Management wants to provide comfort to its current and future shareholders that they have no plans on extensive dilution in the future.
  • The Company does not need billions and billions of authorized shares that serve no purpose other than making shareholders and prospective shareholders nervous.

Billtrust To Become Publicly Traded Company Through Combination With South Mountain Merger Corporation

Retrieved on: 
Monday, October 19, 2020
Finance, Corporate finance, Financial markets, Financial economics, Equity securities, Stock market, Private equity, Special-purpose acquisition company, Stock, Common stock, NASDAQ, Consolidation

NEW YORK, PHILADELPHIA and LAWRENCEVILLE, N.J., Oct. 19, 2020 /PRNewswire/ -- Billtrust, a leader in B2B order-to-cash solutions, and South Mountain Merger Corporation (Nasdaq: SMMC.U) ("South Mountain"), a publicly traded special purpose acquisition company, today announced they have entered into a definitive business combination agreement.

Key Points: 
  • NEW YORK, PHILADELPHIA and LAWRENCEVILLE, N.J., Oct. 19, 2020 /PRNewswire/ -- Billtrust, a leader in B2B order-to-cash solutions, and South Mountain Merger Corporation (Nasdaq: SMMC.U) ("South Mountain"), a publicly traded special purpose acquisition company, today announced they have entered into a definitive business combination agreement.
  • Current stockholders of South Mountain will also become stockholders of the Company and will exchange their shares of South Mountain common stock for common stock of the Company on a share for share basis.
  • This communication is being made in respect of the proposed business combination transaction involving South Mountain and Billtrust.
  • However, while South Mountain and Billtrust may elect to update these forward-looking statements at some point in the future, South Mountain and Billtrust specifically disclaim any obligation to do so.